DualityBio-B (HKEX: 09606) has announced a share buyback transaction. On June 4, 2026, the company utilized HK$6.4558 million to repurchase 34,000 of its own shares.

In a separate transaction, the company issued 10,100 ordinary shares. These shares were issued as a result of exercising options granted under a pre-IPO share incentive scheme. This scheme was originally adopted on February 28, 2021, and subsequently amended on June 25, 2023.